Healthcare and Life Sciences
Offer
Back to top

Introduction

Date: Monday, July 17, 2023
Time: 9:00 a.m.–10:00 a.m. PT
Duration: 1 hour


Dr. Tychele Turner, from the Washington University School of Medicine in St. Louis, will present her lab's development of a computational workflow, called HAT, to detect de novo variants from whole-exome and whole-genome sequencing datasets. She’ll detail the development of this hybrid CPU/GPU workflow and discuss the application to >6,000 parent-child sequenced families. Dr. Turner will also describe her lab’s utilization of GPUs in detecting variants from long-read sequencing data.


Dr. Turner’s talk will focus on areas of particular utility of GPU-based acceleration of genomic tools, including her lab’s use of NVIDIA Parabricks®, a suite of GPU-accelerated and deep learning industry-standard genomics analysis tools for next-generation sequencing data.



In this webinar you will:
  • Understand what a de novo variant is and how it is detected from sequencing data
  • Learn key uses of deep learning-based variant calling to detect de novo variants
  • Identify key differences between short- and long-read sequencing
  • Learn key uses of GPU-based acceleration to assess long-read sequencing data

NVIDIA Parabricks is free for anyone. Download it today to try it out on your DNA and RNA data.

Webinar Registration

THANK YOU FOR REGISTERING FOR THE WEBINAR



You will receive an email with instructions on how to join the webinar shortly.

Main Content

maincontent goes here

Content

Content goes here

Content

content goes here

main image description

Content

Content goes here

Content

DGX Station Datasheet

Get a quick low-down and technical specs for the DGX Station.
DGX Station Whitepaper

Dive deeper into the DGX Station and learn more about the architecture, NVLink, frameworks, tools and more.
DGX Station Whitepaper

Dive deeper into the DGX Station and learn more about the architecture, NVLink, frameworks, tools and more.
DGX Station Whitepaper

Dive deeper into the DGX Station and learn more about the architecture, NVLink, frameworks, tools and more.

Content

Content goes here

Speakers

Dr. Tychele Turner
PI/Assistant Professor, Washington University School of Medicine
Dr. Tychele Turner is a geneticist/genomicist with a deep interest in understanding the genetic architecture of human disease. Dr. Turner completed her undergraduate training in genomics and molecular genetics at Michigan State University, followed by graduate work at the Johns Hopkins University School of Medicine, where she received her Ph.D. in human genetics and molecular biology. She then performed her postdoctoral work in the Department of Genome Sciences at the University of Washington. In September 2019, Dr. Turner, an assistant professor, opened her independent laboratory in the Department of Genetics at Washington University School of Medicine in St. Louis. Her lab is currently focused on the study of noncoding variation in autism, precision genomics in 9p minus syndrome, optimization of genomic workflows, and the application of long-read sequencing to human genetics.
Harry Clifford
Head of Genomics Product, NVIDIA
As the product lead for genomics at NVIDIA, Harry Clifford leverages NVIDIA’s expertise in AI, high performance computing (HPC), and data analytics stacks to bring HPC to the genomics field. His background is in bioinformatics and functional genomics, including a Ph.D. from the University of Oxford, post-doctoral experience in the biopharma industry and at the University of Cambridge, and entrepreneurial experience in the biotech sector. Clifford was listed in Forbes’ “30 Under 30” after co-founding precision oncology company CCG.ai (acquired by Dante Genomics), a Y Combinator and Merck Accelerator-backed startup delivering decision support via deep learning.
Presenter 3 Name
Presenter 3 Title
Presenter 3 Bio
Presenter 4 Name
Job Title 4
Presenter 4 Bio


Main CTA for lightbox form use class="lightbox" CTA

Content Title

Content here

Register

Webinar: Description here

Date & Time: Wednesday, April 22, 2018